Recent Investment Analysts’ Ratings Updates for Aveanna Healthcare (AVAH)

A number of firms have modified their ratings and price targets on shares of Aveanna Healthcare (NASDAQ: AVAH) recently:

• 10/28/2025 – Aveanna Healthcare had its price target raised by analysts at Jefferies Financial Group Inc. from $11.00 to $12.50. They now have a “buy” rating on the stock.
• 10/24/2025 – Aveanna Healthcare had its price target raised by analysts at Royal Bank Of Canada from $8.00 to $10.00. They now have a “sector perform” rating on the stock.
• 10/20/2025 – Aveanna Healthcare was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 10/13/2025 – Aveanna Healthcare had its price target raised by analysts at UBS Group AG from $8.00 to $9.00. They now have a “neutral” rating on the stock.
• 10/8/2025 – Aveanna Healthcare had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 9/27/2025 – Aveanna Healthcare had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 9/18/2025 – Aveanna Healthcare was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $10.00 price target on the stock, up previously from $6.00.

Insider Activity at Aveanna Healthcare

In related news, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the stock in a transaction on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the completion of the sale, the insider directly owned 362,746 shares in the company, valued at approximately $3,264,714. This represents a 80.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of the stock in a transaction on Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $11,267,181.00. Following the completion of the sale, the insider owned 19,292,787 shares of the company’s stock, valued at approximately $173,635,083. This represents a 6.09% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 32,597,968 shares of company stock worth $293,381,712. Corporate insiders own 7.80% of the company’s stock.

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.